zeposia
bristol-myers squibb pharma eeig - ozanimod stutt og long-term - multiple sclerosis, relapsing-remitting; colitis, ulcerative - Ónæmisbælandi lyf - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
animed vet (anispray) húðúði, dreifa 2,45 % w/w
animedica gmbh* - chlortetracycline hydrochloride - húðúði, dreifa - 2,45 % w/w
genestran vet stungulyf, lausn 75 míkróg/ml
animedica gmbh* - cloprostenolum natríum - stungulyf, lausn - 75 míkróg/ml
menbutil (genabiline) stungulyf, lausn 100 mg/ml
animedica gmbh - menbutone - stungulyf, lausn - 100 mg/ml
coxevac
ceva santé animale - óvirkt coxiella burnetii bóluefni, stofn nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.
enrotron flavour (enrotron) tafla 150 mg
animedica gmbh* - enrofloxacinum inn - tafla - 150 mg
enrotron flavour tafla 50 mg
animedica gmbh* - enrofloxacinum inn - tafla - 50 mg
morphasol vet stungulyf, lausn 4 mg/ml
animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 4 mg/ml
procapen vet spenalyf, dreifa 3 g
animedica gmbh* - benzylpenicillinprocainum - spenalyf, dreifa - 3 g
torphasol vet (morphasol) stungulyf, lausn 10 mg/ml
animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 10 mg/ml